These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 31269967

  • 1. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
    Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T.
    Pediatr Rheumatol Online J; 2019 Jul 03; 17(1):34. PubMed ID: 31269967
    [Abstract] [Full Text] [Related]

  • 2. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
    Wang Z, Xu Y, Zhou H, Wang Y, Li W, Lu Z, Jiang Z, Gu X, Zheng H, Zeng L, Huang P, Zhang L, Gu X.
    Cardiovasc Ther; 2020 Jul 03; 2020():3568608. PubMed ID: 32256707
    [Abstract] [Full Text] [Related]

  • 3. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS.
    Rheumatology (Oxford); 2019 May 01; 58(5):770-775. PubMed ID: 30535242
    [Abstract] [Full Text] [Related]

  • 4. Association of Genetic Polymorphisms in Kawasaki Disease with the Response to Intravenous Immunoglobulin Therapy.
    Sapountzi E, Fidani L, Giannopoulos A, Galli-Tsinopoulou A.
    Pediatr Cardiol; 2023 Jan 01; 44(1):1-12. PubMed ID: 35908117
    [Abstract] [Full Text] [Related]

  • 5. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
    Kuo HC, Wong HS, Chang WP, Chen BK, Wu MS, Yang KD, Hsieh KS, Hsu YW, Liu SF, Liu X, Chang WC.
    Circ Cardiovasc Genet; 2017 Oct 01; 10(5):e001625. PubMed ID: 29025760
    [Abstract] [Full Text] [Related]

  • 6. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
    [Abstract] [Full Text] [Related]

  • 7. A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.
    Kuo HC, Hsu YW, Wu CM, Chen SH, Hung KS, Chang WP, Yang KD, Hsieh KS, Chen WC, Onouchi Y, Chang WC.
    PLoS One; 2013 Jun 01; 8(7):e69685. PubMed ID: 23894522
    [Abstract] [Full Text] [Related]

  • 8. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
    Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Mellis S, Lin C, Burns JC.
    Hum Immunol; 2010 Sep 01; 71(9):865-73. PubMed ID: 20600450
    [Abstract] [Full Text] [Related]

  • 9. Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease.
    Kim HJ, Kim JJ, Yun SW, Yu JJ, Yoon KL, Lee KY, Kil HR, Kim GB, Han MK, Song MS, Lee HD, Ha KS, Hong YM, Jang GY, Lee JK, Korean Kawasaki Disease Genetics Consortium.
    J Hum Genet; 2020 Apr 01; 65(4):421-426. PubMed ID: 31965063
    [Abstract] [Full Text] [Related]

  • 10. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Apr 01; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 11. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
    Liang YC, Chang CH, Lin MT, Kao FY, Huang SK, Wu MH.
    Pediatr Res; 2020 Apr 01; 87(5):961-966. PubMed ID: 31711068
    [Abstract] [Full Text] [Related]

  • 12. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
    Kardiol Pol; 2017 Apr 01; 75(3):261-266. PubMed ID: 27995598
    [Abstract] [Full Text] [Related]

  • 13. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
    Tang B, Lo HH, Lei C, U KI, Hsiao WW, Guo X, Bai J, Wong VK, Law BY.
    Phytomedicine; 2020 Apr 15; 70():153208. PubMed ID: 32283413
    [Abstract] [Full Text] [Related]

  • 15. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
    Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
    Ther Apher Dial; 2015 Apr 15; 19(2):171-7. PubMed ID: 25257673
    [Abstract] [Full Text] [Related]

  • 16. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.
    Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, Suenaga T, Honda T, Honda A, Kobayashi H, Takeuchi T, Yoshikawa N, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Ebata R, Higashi K, Ozaki K, Sasago K, Tanaka T, Hata A.
    Pharmacogenomics J; 2013 Feb 15; 13(1):52-9. PubMed ID: 21987091
    [Abstract] [Full Text] [Related]

  • 17. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
    Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, He W, Ahuja SK, Burns JC.
    PLoS One; 2010 Jul 07; 5(7):e11458. PubMed ID: 20628649
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
    Ogihara Y, Ogata S, Nomoto K, Ebato T, Sato K, Kokubo K, Kobayashi H, Ishii M.
    Pediatr Res; 2014 Sep 07; 76(3):287-93. PubMed ID: 24964229
    [Abstract] [Full Text] [Related]

  • 19. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
    Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.
    Arthritis Rheumatol; 2015 Mar 07; 67(3):828-36. PubMed ID: 25470559
    [Abstract] [Full Text] [Related]

  • 20. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 07; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.